• 30TH JUNE 2023

    June 2023 Price Concessions Final Update

    Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners (our members), the Department has today (30/06/2023) announced the following list of final price concessions for June 2023: Drug Pack size Price concession * Alginate raft-forming oral suspension sugar free 500 £3.80 Amiloride

    Read more
    • 30TH JUNE 2023

    NHS and Government publish Workforce Plan

    A plan to increase and develop the NHS workforce, including community pharmacists and their teams, has been published by the Government and NHS today. The long awaited NHS Long Term Workforce Plan maps out a strategy to recruit and retain hundreds of thousands more staff spanning 15 years. Its projections suggest that, by 2036/37, the

    Read more
    • 30TH JUNE 2023

    Medicine Supply Notification: GLP-1 receptor agonists* used in the management of type 2 diabetes

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for GLP-1 receptor agonists* used in the management of type 2 diabetes. *Annex 4 lists individual medicines affected MSN/2023/061 Tier 3 – high impact Date of issue 27th June 2023 There are very limited, intermittent supplies of all glucagon-like peptide-1 receptor agonists

    Read more
    • 30TH JUNE 2023

    July 2023 Category M prices announced

    The Drug Tariff Category M pricelist for July 2023 has been published on the NHS Business Services Authority (NHSBSA) website. The July Category M prices reflect an increase in reimbursement levels of approximately £5m per quarter on like for like entries. This is the net effect of 2 elements; an adjustment of -£23.8m, in light

    Read more
    • 30TH JUNE 2023

    Two SSPs for Clarithromycin oral suspensions further extended

    The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocols (SSPs) for Clarithromycin 125mg/5ml and 250mg/5ml oral suspensions (SSP053 and SSP054). SSP0053 and SSP054 were due to expire on 23 June but the end date has been further extended to Friday 21 July 2023. The Department of Health

    Read more